Nature, Published online: 15 April 2026; doi:10.1038/s41586-026-10353-6 mRNA–lipid-nanoparticle vaccines do not require type 1 conventional dendritic (cDC1) cells or the WDFY4-dependent cross-presentation pathway for CD8+ T cell priming but, instead,…
Anonymous readers can preview up to 1024 characters here. Log in to unlock the full article once ingest succeeds.